Defence Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 1, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	43	38	34	128	73	245
Market Cap Growth	-24.30%	13.68%	-73.58%	74.18%	-70.15%	-
Enterprise Value	44	38	35	126	72	239
Last Close Price	0.57	0.70	0.74	2.92	2.00	7.05
PB Ratio	-35.20	-30.50	-9.40	81.44	-188.95	44.72
P/TBV Ratio	-	-	-	83.51	-	45.09
Debt / Equity Ratio	-1.22	-1.20	-0.49	1.12	-	-
Net Debt / Equity Ratio	-0.44	-0.22	-0.47	-0.67	1.31	-0.99
Net Debt / EBITDA Ratio	-0.13	-0.09	-0.13	0.16	-	-
Net Debt / FCF Ratio	-0.11	-0.08	-0.38	0.14	0.08	2.38
Quick Ratio	1.06	0.49	0.04	13.35	0.48	45.19
Current Ratio	1.08	0.50	0.05	15.58	0.61	45.51
Return on Equity (ROE)	-	-	-	-1147.59%	-288.03%	-77.80%
Return on Assets (ROA)	-288.45%	-187.25%	-397.30%	-190.91%	-143.66%	-46.96%
Return on Capital Employed (ROCE)	-1551.30%	254.00%	356.40%	-196.10%	1876.80%	-51.50%
Earnings Yield	-10.06%	-9.19%	-39.15%	-5.30%	-10.03%	-1.17%
FCF Yield	-11.50%	-8.88%	-13.33%	-6.05%	-8.25%	-0.93%
Buyback Yield / Dilution	-19.06%	-11.64%	-12.54%	-9.93%	-35.65%	-2719.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.